Global Haemophilus Influenzae Type B Vaccine Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Haemophilus Influenzae Type B Vaccine will have significant change from previous year. According to our (LP Information) latest study, the global Haemophilus Influenzae Type B Vaccine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Haemophilus Influenzae Type B Vaccine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Haemophilus Influenzae Type B Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Haemophilus Influenzae Type B Vaccine market, reaching US$ million by the year 2028. As for the Europe Haemophilus Influenzae Type B Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Haemophilus Influenzae Type B Vaccine players cover Novartis, Merck, Sanofi, and GlaxoSmithKline, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Haemophilus Influenzae Type B Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
As the global economy mends, the 2021 growth of Haemophilus Influenzae Type B Vaccine will have significant change from previous year. According to our (LP Information) latest study, the global Haemophilus Influenzae Type B Vaccine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Haemophilus Influenzae Type B Vaccine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Haemophilus Influenzae Type B Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Haemophilus Influenzae Type B Vaccine market, reaching US$ million by the year 2028. As for the Europe Haemophilus Influenzae Type B Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Haemophilus Influenzae Type B Vaccine players cover Novartis, Merck, Sanofi, and GlaxoSmithKline, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Haemophilus Influenzae Type B Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
- Liquid Monovalent HIB
- Liquid Combination HIB
- Lyophilized Monovalent HIB
- Lyophilized Combination HIB
- Hospital
- Research Institutions
- Pharmaceutical and Biotechnology Companies
- Academic Institutions
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis
- Merck
- Sanofi
- GlaxoSmithKline
- Takeda Pharmaceuticals Company
- Walvax Biotechnology
- Lanzhou Institute of Biologica
- Immunize BC
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Haemophilus Influenzae Type B Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Haemophilus Influenzae Type B Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Haemophilus Influenzae Type B Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Haemophilus Influenzae Type B Vaccine Segment by Type
2.2.1 Liquid Monovalent HIB
2.2.2 Liquid Combination HIB
2.2.3 Lyophilized Monovalent HIB
2.2.4 Lyophilized Combination HIB
2.3 Haemophilus Influenzae Type B Vaccine Sales by Type
2.3.1 Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Haemophilus Influenzae Type B Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Haemophilus Influenzae Type B Vaccine Sale Price by Type (2017-2022)
2.4 Haemophilus Influenzae Type B Vaccine Segment by Application
2.4.1 Hospital
2.4.2 Research Institutions
2.4.3 Pharmaceutical and Biotechnology Companies
2.4.4 Academic Institutions
2.4.5 Other
2.5 Haemophilus Influenzae Type B Vaccine Sales by Application
2.5.1 Global Haemophilus Influenzae Type B Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Haemophilus Influenzae Type B Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Haemophilus Influenzae Type B Vaccine Sale Price by Application (2017-2022)
3 GLOBAL HAEMOPHILUS INFLUENZAE TYPE B VACCINE BY COMPANY
3.1 Global Haemophilus Influenzae Type B Vaccine Breakdown Data by Company
3.1.1 Global Haemophilus Influenzae Type B Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Haemophilus Influenzae Type B Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Haemophilus Influenzae Type B Vaccine Revenue by Company (2020-2022)
3.2.2 Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Haemophilus Influenzae Type B Vaccine Sale Price by Company
3.4 Key Manufacturers Haemophilus Influenzae Type B Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Haemophilus Influenzae Type B Vaccine Product Location Distribution
3.4.2 Players Haemophilus Influenzae Type B Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR HAEMOPHILUS INFLUENZAE TYPE B VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Haemophilus Influenzae Type B Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Haemophilus Influenzae Type B Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Haemophilus Influenzae Type B Vaccine Annual Revenue by Geographic Region
4.2 World Historic Haemophilus Influenzae Type B Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Haemophilus Influenzae Type B Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Haemophilus Influenzae Type B Vaccine Annual Revenue by Country/Region
4.3 Americas Haemophilus Influenzae Type B Vaccine Sales Growth
4.4 APAC Haemophilus Influenzae Type B Vaccine Sales Growth
4.5 Europe Haemophilus Influenzae Type B Vaccine Sales Growth
4.6 Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales Growth
5 AMERICAS
5.1 Americas Haemophilus Influenzae Type B Vaccine Sales by Country
5.1.1 Americas Haemophilus Influenzae Type B Vaccine Sales by Country (2017-2022)
5.1.2 Americas Haemophilus Influenzae Type B Vaccine Revenue by Country (2017-2022)
5.2 Americas Haemophilus Influenzae Type B Vaccine Sales by Type
5.3 Americas Haemophilus Influenzae Type B Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Haemophilus Influenzae Type B Vaccine Sales by Region
6.1.1 APAC Haemophilus Influenzae Type B Vaccine Sales by Region (2017-2022)
6.1.2 APAC Haemophilus Influenzae Type B Vaccine Revenue by Region (2017-2022)
6.2 APAC Haemophilus Influenzae Type B Vaccine Sales by Type
6.3 APAC Haemophilus Influenzae Type B Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Haemophilus Influenzae Type B Vaccine by Country
7.1.1 Europe Haemophilus Influenzae Type B Vaccine Sales by Country (2017-2022)
7.1.2 Europe Haemophilus Influenzae Type B Vaccine Revenue by Country (2017-2022)
7.2 Europe Haemophilus Influenzae Type B Vaccine Sales by Type
7.3 Europe Haemophilus Influenzae Type B Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Haemophilus Influenzae Type B Vaccine by Country
8.1.1 Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Haemophilus Influenzae Type B Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales by Type
8.3 Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Haemophilus Influenzae Type B Vaccine
10.3 Manufacturing Process Analysis of Haemophilus Influenzae Type B Vaccine
10.4 Industry Chain Structure of Haemophilus Influenzae Type B Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Haemophilus Influenzae Type B Vaccine Distributors
11.3 Haemophilus Influenzae Type B Vaccine Customer
12 WORLD FORECAST REVIEW FOR HAEMOPHILUS INFLUENZAE TYPE B VACCINE BY GEOGRAPHIC REGION
12.1 Global Haemophilus Influenzae Type B Vaccine Market Size Forecast by Region
12.1.1 Global Haemophilus Influenzae Type B Vaccine Forecast by Region (2023-2028)
12.1.2 Global Haemophilus Influenzae Type B Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Haemophilus Influenzae Type B Vaccine Forecast by Type
12.7 Global Haemophilus Influenzae Type B Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Haemophilus Influenzae Type B Vaccine Product Offered
13.1.3 Novartis Haemophilus Influenzae Type B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Haemophilus Influenzae Type B Vaccine Product Offered
13.2.3 Merck Haemophilus Influenzae Type B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Haemophilus Influenzae Type B Vaccine Product Offered
13.3.3 Sanofi Haemophilus Influenzae Type B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 GlaxoSmithKline
13.4.1 GlaxoSmithKline Company Information
13.4.2 GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Product Offered
13.4.3 GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 GlaxoSmithKline Main Business Overview
13.4.5 GlaxoSmithKline Latest Developments
13.5 Takeda Pharmaceuticals Company
13.5.1 Takeda Pharmaceuticals Company Company Information
13.5.2 Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Product Offered
13.5.3 Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Takeda Pharmaceuticals Company Main Business Overview
13.5.5 Takeda Pharmaceuticals Company Latest Developments
13.6 Walvax Biotechnology
13.6.1 Walvax Biotechnology Company Information
13.6.2 Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Product Offered
13.6.3 Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Walvax Biotechnology Main Business Overview
13.6.5 Walvax Biotechnology Latest Developments
13.7 Lanzhou Institute of Biologica
13.7.1 Lanzhou Institute of Biologica Company Information
13.7.2 Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Product Offered
13.7.3 Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Lanzhou Institute of Biologica Main Business Overview
13.7.5 Lanzhou Institute of Biologica Latest Developments
13.8 Immunize BC
13.8.1 Immunize BC Company Information
13.8.2 Immunize BC Haemophilus Influenzae Type B Vaccine Product Offered
13.8.3 Immunize BC Haemophilus Influenzae Type B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Immunize BC Main Business Overview
13.8.5 Immunize BC Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Haemophilus Influenzae Type B Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Haemophilus Influenzae Type B Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Haemophilus Influenzae Type B Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Haemophilus Influenzae Type B Vaccine Segment by Type
2.2.1 Liquid Monovalent HIB
2.2.2 Liquid Combination HIB
2.2.3 Lyophilized Monovalent HIB
2.2.4 Lyophilized Combination HIB
2.3 Haemophilus Influenzae Type B Vaccine Sales by Type
2.3.1 Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Haemophilus Influenzae Type B Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Haemophilus Influenzae Type B Vaccine Sale Price by Type (2017-2022)
2.4 Haemophilus Influenzae Type B Vaccine Segment by Application
2.4.1 Hospital
2.4.2 Research Institutions
2.4.3 Pharmaceutical and Biotechnology Companies
2.4.4 Academic Institutions
2.4.5 Other
2.5 Haemophilus Influenzae Type B Vaccine Sales by Application
2.5.1 Global Haemophilus Influenzae Type B Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Haemophilus Influenzae Type B Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Haemophilus Influenzae Type B Vaccine Sale Price by Application (2017-2022)
3 GLOBAL HAEMOPHILUS INFLUENZAE TYPE B VACCINE BY COMPANY
3.1 Global Haemophilus Influenzae Type B Vaccine Breakdown Data by Company
3.1.1 Global Haemophilus Influenzae Type B Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Haemophilus Influenzae Type B Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Haemophilus Influenzae Type B Vaccine Revenue by Company (2020-2022)
3.2.2 Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Haemophilus Influenzae Type B Vaccine Sale Price by Company
3.4 Key Manufacturers Haemophilus Influenzae Type B Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Haemophilus Influenzae Type B Vaccine Product Location Distribution
3.4.2 Players Haemophilus Influenzae Type B Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR HAEMOPHILUS INFLUENZAE TYPE B VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Haemophilus Influenzae Type B Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Haemophilus Influenzae Type B Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Haemophilus Influenzae Type B Vaccine Annual Revenue by Geographic Region
4.2 World Historic Haemophilus Influenzae Type B Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Haemophilus Influenzae Type B Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Haemophilus Influenzae Type B Vaccine Annual Revenue by Country/Region
4.3 Americas Haemophilus Influenzae Type B Vaccine Sales Growth
4.4 APAC Haemophilus Influenzae Type B Vaccine Sales Growth
4.5 Europe Haemophilus Influenzae Type B Vaccine Sales Growth
4.6 Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales Growth
5 AMERICAS
5.1 Americas Haemophilus Influenzae Type B Vaccine Sales by Country
5.1.1 Americas Haemophilus Influenzae Type B Vaccine Sales by Country (2017-2022)
5.1.2 Americas Haemophilus Influenzae Type B Vaccine Revenue by Country (2017-2022)
5.2 Americas Haemophilus Influenzae Type B Vaccine Sales by Type
5.3 Americas Haemophilus Influenzae Type B Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Haemophilus Influenzae Type B Vaccine Sales by Region
6.1.1 APAC Haemophilus Influenzae Type B Vaccine Sales by Region (2017-2022)
6.1.2 APAC Haemophilus Influenzae Type B Vaccine Revenue by Region (2017-2022)
6.2 APAC Haemophilus Influenzae Type B Vaccine Sales by Type
6.3 APAC Haemophilus Influenzae Type B Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Haemophilus Influenzae Type B Vaccine by Country
7.1.1 Europe Haemophilus Influenzae Type B Vaccine Sales by Country (2017-2022)
7.1.2 Europe Haemophilus Influenzae Type B Vaccine Revenue by Country (2017-2022)
7.2 Europe Haemophilus Influenzae Type B Vaccine Sales by Type
7.3 Europe Haemophilus Influenzae Type B Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Haemophilus Influenzae Type B Vaccine by Country
8.1.1 Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Haemophilus Influenzae Type B Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales by Type
8.3 Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Haemophilus Influenzae Type B Vaccine
10.3 Manufacturing Process Analysis of Haemophilus Influenzae Type B Vaccine
10.4 Industry Chain Structure of Haemophilus Influenzae Type B Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Haemophilus Influenzae Type B Vaccine Distributors
11.3 Haemophilus Influenzae Type B Vaccine Customer
12 WORLD FORECAST REVIEW FOR HAEMOPHILUS INFLUENZAE TYPE B VACCINE BY GEOGRAPHIC REGION
12.1 Global Haemophilus Influenzae Type B Vaccine Market Size Forecast by Region
12.1.1 Global Haemophilus Influenzae Type B Vaccine Forecast by Region (2023-2028)
12.1.2 Global Haemophilus Influenzae Type B Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Haemophilus Influenzae Type B Vaccine Forecast by Type
12.7 Global Haemophilus Influenzae Type B Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Haemophilus Influenzae Type B Vaccine Product Offered
13.1.3 Novartis Haemophilus Influenzae Type B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Haemophilus Influenzae Type B Vaccine Product Offered
13.2.3 Merck Haemophilus Influenzae Type B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Haemophilus Influenzae Type B Vaccine Product Offered
13.3.3 Sanofi Haemophilus Influenzae Type B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 GlaxoSmithKline
13.4.1 GlaxoSmithKline Company Information
13.4.2 GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Product Offered
13.4.3 GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 GlaxoSmithKline Main Business Overview
13.4.5 GlaxoSmithKline Latest Developments
13.5 Takeda Pharmaceuticals Company
13.5.1 Takeda Pharmaceuticals Company Company Information
13.5.2 Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Product Offered
13.5.3 Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Takeda Pharmaceuticals Company Main Business Overview
13.5.5 Takeda Pharmaceuticals Company Latest Developments
13.6 Walvax Biotechnology
13.6.1 Walvax Biotechnology Company Information
13.6.2 Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Product Offered
13.6.3 Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Walvax Biotechnology Main Business Overview
13.6.5 Walvax Biotechnology Latest Developments
13.7 Lanzhou Institute of Biologica
13.7.1 Lanzhou Institute of Biologica Company Information
13.7.2 Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Product Offered
13.7.3 Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Lanzhou Institute of Biologica Main Business Overview
13.7.5 Lanzhou Institute of Biologica Latest Developments
13.8 Immunize BC
13.8.1 Immunize BC Company Information
13.8.2 Immunize BC Haemophilus Influenzae Type B Vaccine Product Offered
13.8.3 Immunize BC Haemophilus Influenzae Type B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Immunize BC Main Business Overview
13.8.5 Immunize BC Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Haemophilus Influenzae Type B Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Haemophilus Influenzae Type B Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Liquid Monovalent HIB
Table 4. Major Players of Liquid Combination HIB
Table 5. Major Players of Lyophilized Monovalent HIB
Table 6. Major Players of Lyophilized Combination HIB
Table 7. Global Haemophilus Influenzae Type B Vaccine Sales by Type (2017-2022) & (M Doses)
Table 8. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2017-2022)
Table 9. Global Haemophilus Influenzae Type B Vaccine Revenue by Type (2017-2022) & ($ million)
Table 10. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2017-2022)
Table 11. Global Haemophilus Influenzae Type B Vaccine Sale Price by Type (2017-2022) & (USD/Dose)
Table 12. Global Haemophilus Influenzae Type B Vaccine Sales by Application (2017-2022) & (M Doses)
Table 13. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2017-2022)
Table 14. Global Haemophilus Influenzae Type B Vaccine Revenue by Application (2017-2022)
Table 15. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application (2017-2022)
Table 16. Global Haemophilus Influenzae Type B Vaccine Sale Price by Application (2017-2022) & (USD/Dose)
Table 17. Global Haemophilus Influenzae Type B Vaccine Sales by Company (2020-2022) & (M Doses)
Table 18. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Company (2020-2022)
Table 19. Global Haemophilus Influenzae Type B Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Company (2020-2022)
Table 21. Global Haemophilus Influenzae Type B Vaccine Sale Price by Company (2020-2022) & (USD/Dose)
Table 22. Key Manufacturers Haemophilus Influenzae Type B Vaccine Producing Area Distribution and Sales Area
Table 23. Players Haemophilus Influenzae Type B Vaccine Products Offered
Table 24. Haemophilus Influenzae Type B Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Haemophilus Influenzae Type B Vaccine Sales by Geographic Region (2017-2022) & (M Doses)
Table 28. Global Haemophilus Influenzae Type B Vaccine Sales Market Share Geographic Region (2017-2022)
Table 29. Global Haemophilus Influenzae Type B Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Haemophilus Influenzae Type B Vaccine Sales by Country/Region (2017-2022) & (M Doses)
Table 32. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Country/Region (2017-2022)
Table 33. Global Haemophilus Influenzae Type B Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Haemophilus Influenzae Type B Vaccine Sales by Country (2017-2022) & (M Doses)
Table 36. Americas Haemophilus Influenzae Type B Vaccine Sales Market Share by Country (2017-2022)
Table 37. Americas Haemophilus Influenzae Type B Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country (2017-2022)
Table 39. Americas Haemophilus Influenzae Type B Vaccine Sales by Type (2017-2022) & (M Doses)
Table 40. Americas Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2017-2022)
Table 41. Americas Haemophilus Influenzae Type B Vaccine Sales by Application (2017-2022) & (M Doses)
Table 42. Americas Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2017-2022)
Table 43. APAC Haemophilus Influenzae Type B Vaccine Sales by Region (2017-2022) & (M Doses)
Table 44. APAC Haemophilus Influenzae Type B Vaccine Sales Market Share by Region (2017-2022)
Table 45. APAC Haemophilus Influenzae Type B Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region (2017-2022)
Table 47. APAC Haemophilus Influenzae Type B Vaccine Sales by Type (2017-2022) & (M Doses)
Table 48. APAC Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2017-2022)
Table 49. APAC Haemophilus Influenzae Type B Vaccine Sales by Application (2017-2022) & (M Doses)
Table 50. APAC Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2017-2022)
Table 51. Europe Haemophilus Influenzae Type B Vaccine Sales by Country (2017-2022) & (M Doses)
Table 52. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Country (2017-2022)
Table 53. Europe Haemophilus Influenzae Type B Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country (2017-2022)
Table 55. Europe Haemophilus Influenzae Type B Vaccine Sales by Type (2017-2022) & (M Doses)
Table 56. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2017-2022)
Table 57. Europe Haemophilus Influenzae Type B Vaccine Sales by Application (2017-2022) & (M Doses)
Table 58. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales by Country (2017-2022) & (M Doses)
Table 60. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Haemophilus Influenzae Type B Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales by Type (2017-2022) & (M Doses)
Table 64. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales by Application (2017-2022) & (M Doses)
Table 66. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Haemophilus Influenzae Type B Vaccine
Table 68. Key Market Challenges & Risks of Haemophilus Influenzae Type B Vaccine
Table 69. Key Industry Trends of Haemophilus Influenzae Type B Vaccine
Table 70. Haemophilus Influenzae Type B Vaccine Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Haemophilus Influenzae Type B Vaccine Distributors List
Table 73. Haemophilus Influenzae Type B Vaccine Customer List
Table 74. Global Haemophilus Influenzae Type B Vaccine Sales Forecast by Region (2023-2028) & (M Doses)
Table 75. Global Haemophilus Influenzae Type B Vaccine Sales Market Forecast by Region
Table 76. Global Haemophilus Influenzae Type B Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Haemophilus Influenzae Type B Vaccine Sales Forecast by Country (2023-2028) & (M Doses)
Table 79. Americas Haemophilus Influenzae Type B Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Haemophilus Influenzae Type B Vaccine Sales Forecast by Region (2023-2028) & (M Doses)
Table 81. APAC Haemophilus Influenzae Type B Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Haemophilus Influenzae Type B Vaccine Sales Forecast by Country (2023-2028) & (M Doses)
Table 83. Europe Haemophilus Influenzae Type B Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales Forecast by Country (2023-2028) & (M Doses)
Table 85. Middle East & Africa Haemophilus Influenzae Type B Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Haemophilus Influenzae Type B Vaccine Sales Forecast by Type (2023-2028) & (M Doses)
Table 87. Global Haemophilus Influenzae Type B Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Haemophilus Influenzae Type B Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Haemophilus Influenzae Type B Vaccine Sales Forecast by Application (2023-2028) & (M Doses)
Table 91. Global Haemophilus Influenzae Type B Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Haemophilus Influenzae Type B Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 94. Novartis Basic Information, Haemophilus Influenzae Type B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 95. Novartis Haemophilus Influenzae Type B Vaccine Product Offered
Table 96. Novartis Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 97. Novartis Main Business
Table 98. Novartis Latest Developments
Table 99. Merck Basic Information, Haemophilus Influenzae Type B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 100. Merck Haemophilus Influenzae Type B Vaccine Product Offered
Table 101. Merck Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 102. Merck Main Business
Table 103. Merck Latest Developments
Table 104. Sanofi Basic Information, Haemophilus Influenzae Type B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 105. Sanofi Haemophilus Influenzae Type B Vaccine Product Offered
Table 106. Sanofi Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 107. Sanofi Main Business
Table 108. Sanofi Latest Developments
Table 109. GlaxoSmithKline Basic Information, Haemophilus Influenzae Type B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 110. GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Product Offered
Table 111. GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 112. GlaxoSmithKline Main Business
Table 113. GlaxoSmithKline Latest Developments
Table 114. Takeda Pharmaceuticals Company Basic Information, Haemophilus Influenzae Type B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 115. Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Product Offered
Table 116. Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 117. Takeda Pharmaceuticals Company Main Business
Table 118. Takeda Pharmaceuticals Company Latest Developments
Table 119. Walvax Biotechnology Basic Information, Haemophilus Influenzae Type B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 120. Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Product Offered
Table 121. Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 122. Walvax Biotechnology Main Business
Table 123. Walvax Biotechnology Latest Developments
Table 124. Lanzhou Institute of Biologica Basic Information, Haemophilus Influenzae Type B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 125. Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Product Offered
Table 126. Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 127. Lanzhou Institute of Biologica Main Business
Table 128. Lanzhou Institute of Biologica Latest Developments
Table 129. Immunize BC Basic Information, Haemophilus Influenzae Type B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 130. Immunize BC Haemophilus Influenzae Type B Vaccine Product Offered
Table 131. Immunize BC Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 132. Immunize BC Main Business
Table 133. Immunize BC Latest Developments
Table 1. Haemophilus Influenzae Type B Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Haemophilus Influenzae Type B Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Liquid Monovalent HIB
Table 4. Major Players of Liquid Combination HIB
Table 5. Major Players of Lyophilized Monovalent HIB
Table 6. Major Players of Lyophilized Combination HIB
Table 7. Global Haemophilus Influenzae Type B Vaccine Sales by Type (2017-2022) & (M Doses)
Table 8. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2017-2022)
Table 9. Global Haemophilus Influenzae Type B Vaccine Revenue by Type (2017-2022) & ($ million)
Table 10. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2017-2022)
Table 11. Global Haemophilus Influenzae Type B Vaccine Sale Price by Type (2017-2022) & (USD/Dose)
Table 12. Global Haemophilus Influenzae Type B Vaccine Sales by Application (2017-2022) & (M Doses)
Table 13. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2017-2022)
Table 14. Global Haemophilus Influenzae Type B Vaccine Revenue by Application (2017-2022)
Table 15. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application (2017-2022)
Table 16. Global Haemophilus Influenzae Type B Vaccine Sale Price by Application (2017-2022) & (USD/Dose)
Table 17. Global Haemophilus Influenzae Type B Vaccine Sales by Company (2020-2022) & (M Doses)
Table 18. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Company (2020-2022)
Table 19. Global Haemophilus Influenzae Type B Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Company (2020-2022)
Table 21. Global Haemophilus Influenzae Type B Vaccine Sale Price by Company (2020-2022) & (USD/Dose)
Table 22. Key Manufacturers Haemophilus Influenzae Type B Vaccine Producing Area Distribution and Sales Area
Table 23. Players Haemophilus Influenzae Type B Vaccine Products Offered
Table 24. Haemophilus Influenzae Type B Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Haemophilus Influenzae Type B Vaccine Sales by Geographic Region (2017-2022) & (M Doses)
Table 28. Global Haemophilus Influenzae Type B Vaccine Sales Market Share Geographic Region (2017-2022)
Table 29. Global Haemophilus Influenzae Type B Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Haemophilus Influenzae Type B Vaccine Sales by Country/Region (2017-2022) & (M Doses)
Table 32. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Country/Region (2017-2022)
Table 33. Global Haemophilus Influenzae Type B Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Haemophilus Influenzae Type B Vaccine Sales by Country (2017-2022) & (M Doses)
Table 36. Americas Haemophilus Influenzae Type B Vaccine Sales Market Share by Country (2017-2022)
Table 37. Americas Haemophilus Influenzae Type B Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country (2017-2022)
Table 39. Americas Haemophilus Influenzae Type B Vaccine Sales by Type (2017-2022) & (M Doses)
Table 40. Americas Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2017-2022)
Table 41. Americas Haemophilus Influenzae Type B Vaccine Sales by Application (2017-2022) & (M Doses)
Table 42. Americas Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2017-2022)
Table 43. APAC Haemophilus Influenzae Type B Vaccine Sales by Region (2017-2022) & (M Doses)
Table 44. APAC Haemophilus Influenzae Type B Vaccine Sales Market Share by Region (2017-2022)
Table 45. APAC Haemophilus Influenzae Type B Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region (2017-2022)
Table 47. APAC Haemophilus Influenzae Type B Vaccine Sales by Type (2017-2022) & (M Doses)
Table 48. APAC Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2017-2022)
Table 49. APAC Haemophilus Influenzae Type B Vaccine Sales by Application (2017-2022) & (M Doses)
Table 50. APAC Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2017-2022)
Table 51. Europe Haemophilus Influenzae Type B Vaccine Sales by Country (2017-2022) & (M Doses)
Table 52. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Country (2017-2022)
Table 53. Europe Haemophilus Influenzae Type B Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country (2017-2022)
Table 55. Europe Haemophilus Influenzae Type B Vaccine Sales by Type (2017-2022) & (M Doses)
Table 56. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2017-2022)
Table 57. Europe Haemophilus Influenzae Type B Vaccine Sales by Application (2017-2022) & (M Doses)
Table 58. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales by Country (2017-2022) & (M Doses)
Table 60. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Haemophilus Influenzae Type B Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales by Type (2017-2022) & (M Doses)
Table 64. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales by Application (2017-2022) & (M Doses)
Table 66. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Haemophilus Influenzae Type B Vaccine
Table 68. Key Market Challenges & Risks of Haemophilus Influenzae Type B Vaccine
Table 69. Key Industry Trends of Haemophilus Influenzae Type B Vaccine
Table 70. Haemophilus Influenzae Type B Vaccine Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Haemophilus Influenzae Type B Vaccine Distributors List
Table 73. Haemophilus Influenzae Type B Vaccine Customer List
Table 74. Global Haemophilus Influenzae Type B Vaccine Sales Forecast by Region (2023-2028) & (M Doses)
Table 75. Global Haemophilus Influenzae Type B Vaccine Sales Market Forecast by Region
Table 76. Global Haemophilus Influenzae Type B Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Haemophilus Influenzae Type B Vaccine Sales Forecast by Country (2023-2028) & (M Doses)
Table 79. Americas Haemophilus Influenzae Type B Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Haemophilus Influenzae Type B Vaccine Sales Forecast by Region (2023-2028) & (M Doses)
Table 81. APAC Haemophilus Influenzae Type B Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Haemophilus Influenzae Type B Vaccine Sales Forecast by Country (2023-2028) & (M Doses)
Table 83. Europe Haemophilus Influenzae Type B Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales Forecast by Country (2023-2028) & (M Doses)
Table 85. Middle East & Africa Haemophilus Influenzae Type B Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Haemophilus Influenzae Type B Vaccine Sales Forecast by Type (2023-2028) & (M Doses)
Table 87. Global Haemophilus Influenzae Type B Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Haemophilus Influenzae Type B Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Haemophilus Influenzae Type B Vaccine Sales Forecast by Application (2023-2028) & (M Doses)
Table 91. Global Haemophilus Influenzae Type B Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Haemophilus Influenzae Type B Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 94. Novartis Basic Information, Haemophilus Influenzae Type B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 95. Novartis Haemophilus Influenzae Type B Vaccine Product Offered
Table 96. Novartis Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 97. Novartis Main Business
Table 98. Novartis Latest Developments
Table 99. Merck Basic Information, Haemophilus Influenzae Type B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 100. Merck Haemophilus Influenzae Type B Vaccine Product Offered
Table 101. Merck Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 102. Merck Main Business
Table 103. Merck Latest Developments
Table 104. Sanofi Basic Information, Haemophilus Influenzae Type B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 105. Sanofi Haemophilus Influenzae Type B Vaccine Product Offered
Table 106. Sanofi Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 107. Sanofi Main Business
Table 108. Sanofi Latest Developments
Table 109. GlaxoSmithKline Basic Information, Haemophilus Influenzae Type B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 110. GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Product Offered
Table 111. GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 112. GlaxoSmithKline Main Business
Table 113. GlaxoSmithKline Latest Developments
Table 114. Takeda Pharmaceuticals Company Basic Information, Haemophilus Influenzae Type B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 115. Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Product Offered
Table 116. Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 117. Takeda Pharmaceuticals Company Main Business
Table 118. Takeda Pharmaceuticals Company Latest Developments
Table 119. Walvax Biotechnology Basic Information, Haemophilus Influenzae Type B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 120. Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Product Offered
Table 121. Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 122. Walvax Biotechnology Main Business
Table 123. Walvax Biotechnology Latest Developments
Table 124. Lanzhou Institute of Biologica Basic Information, Haemophilus Influenzae Type B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 125. Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Product Offered
Table 126. Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 127. Lanzhou Institute of Biologica Main Business
Table 128. Lanzhou Institute of Biologica Latest Developments
Table 129. Immunize BC Basic Information, Haemophilus Influenzae Type B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 130. Immunize BC Haemophilus Influenzae Type B Vaccine Product Offered
Table 131. Immunize BC Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 132. Immunize BC Main Business
Table 133. Immunize BC Latest Developments
LIST OF FIGURES
Figure 1. Picture of Haemophilus Influenzae Type B Vaccine
Figure 2. Haemophilus Influenzae Type B Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Haemophilus Influenzae Type B Vaccine Sales Growth Rate 2017-2028 (M Doses)
Figure 7. Global Haemophilus Influenzae Type B Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Haemophilus Influenzae Type B Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Liquid Monovalent HIB
Figure 10. Product Picture of Liquid Combination HIB
Figure 11. Product Picture of Lyophilized Monovalent HIB
Figure 12. Product Picture of Lyophilized Combination HIB
Figure 13. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type in 2021
Figure 14. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2017-2022)
Figure 15. Haemophilus Influenzae Type B Vaccine Consumed in Hospital
Figure 16. Global Haemophilus Influenzae Type B Vaccine Market: Hospital (2017-2022) & (M Doses)
Figure 17. Haemophilus Influenzae Type B Vaccine Consumed in Research Institutions
Figure 18. Global Haemophilus Influenzae Type B Vaccine Market: Research Institutions (2017-2022) & (M Doses)
Figure 19. Haemophilus Influenzae Type B Vaccine Consumed in Pharmaceutical and Biotechnology Companies
Figure 20. Global Haemophilus Influenzae Type B Vaccine Market: Pharmaceutical and Biotechnology Companies (2017-2022) & (M Doses)
Figure 21. Haemophilus Influenzae Type B Vaccine Consumed in Academic Institutions
Figure 22. Global Haemophilus Influenzae Type B Vaccine Market: Academic Institutions (2017-2022) & (M Doses)
Figure 23. Haemophilus Influenzae Type B Vaccine Consumed in Other
Figure 24. Global Haemophilus Influenzae Type B Vaccine Market: Other (2017-2022) & (M Doses)
Figure 25. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2017-2022)
Figure 26. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application in 2021
Figure 27. Haemophilus Influenzae Type B Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 28. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Company in 2021
Figure 29. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 30. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Geographic Region in 2021
Figure 31. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Region (2017-2022)
Figure 32. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country/Region in 2021
Figure 33. Americas Haemophilus Influenzae Type B Vaccine Sales 2017-2022 (M Doses)
Figure 34. Americas Haemophilus Influenzae Type B Vaccine Revenue 2017-2022 ($ Millions)
Figure 35. APAC Haemophilus Influenzae Type B Vaccine Sales 2017-2022 (M Doses)
Figure 36. APAC Haemophilus Influenzae Type B Vaccine Revenue 2017-2022 ($ Millions)
Figure 37. Europe Haemophilus Influenzae Type B Vaccine Sales 2017-2022 (M Doses)
Figure 38. Europe Haemophilus Influenzae Type B Vaccine Revenue 2017-2022 ($ Millions)
Figure 39. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales 2017-2022 (M Doses)
Figure 40. Middle East & Africa Haemophilus Influenzae Type B Vaccine Revenue 2017-2022 ($ Millions)
Figure 41. Americas Haemophilus Influenzae Type B Vaccine Sales Market Share by Country in 2021
Figure 42. Americas Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country in 2021
Figure 43. United States Haemophilus Influenzae Type B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Canada Haemophilus Influenzae Type B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. Mexico Haemophilus Influenzae Type B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Brazil Haemophilus Influenzae Type B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 47. APAC Haemophilus Influenzae Type B Vaccine Sales Market Share by Region in 2021
Figure 48. APAC Haemophilus Influenzae Type B Vaccine Revenue Market Share by Regions in 2021
Figure 49. China Haemophilus Influenzae Type B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 50. Japan Haemophilus Influenzae Type B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 51. South Korea Haemophilus Influenzae Type B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. Southeast Asia Haemophilus Influenzae Type B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. India Haemophilus Influenzae Type B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Australia Haemophilus Influenzae Type B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 55. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Country in 2021
Figure 56. Europe Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country in 2021
Figure 57. Germany Haemophilus Influenzae Type B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 58. France Haemophilus Influenzae Type B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. UK Haemophilus Influenzae Type B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. Italy Haemophilus Influenzae Type B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Russia Haemophilus Influenzae Type B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 62. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales Market Share by Country in 2021
Figure 63. Middle East & Africa Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country in 2021
Figure 64. Egypt Haemophilus Influenzae Type B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 65. South Africa Haemophilus Influenzae Type B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 66. Israel Haemophilus Influenzae Type B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 67. Turkey Haemophilus Influenzae Type B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 68. GCC Country Haemophilus Influenzae Type B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 69. Manufacturing Cost Structure Analysis of Haemophilus Influenzae Type B Vaccine in 2021
Figure 70. Manufacturing Process Analysis of Haemophilus Influenzae Type B Vaccine
Figure 71. Industry Chain Structure of Haemophilus Influenzae Type B Vaccine
Figure 72. Channels of Distribution
Figure 73. Distributors Profiles
Figure 1. Picture of Haemophilus Influenzae Type B Vaccine
Figure 2. Haemophilus Influenzae Type B Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Haemophilus Influenzae Type B Vaccine Sales Growth Rate 2017-2028 (M Doses)
Figure 7. Global Haemophilus Influenzae Type B Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Haemophilus Influenzae Type B Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Liquid Monovalent HIB
Figure 10. Product Picture of Liquid Combination HIB
Figure 11. Product Picture of Lyophilized Monovalent HIB
Figure 12. Product Picture of Lyophilized Combination HIB
Figure 13. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type in 2021
Figure 14. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2017-2022)
Figure 15. Haemophilus Influenzae Type B Vaccine Consumed in Hospital
Figure 16. Global Haemophilus Influenzae Type B Vaccine Market: Hospital (2017-2022) & (M Doses)
Figure 17. Haemophilus Influenzae Type B Vaccine Consumed in Research Institutions
Figure 18. Global Haemophilus Influenzae Type B Vaccine Market: Research Institutions (2017-2022) & (M Doses)
Figure 19. Haemophilus Influenzae Type B Vaccine Consumed in Pharmaceutical and Biotechnology Companies
Figure 20. Global Haemophilus Influenzae Type B Vaccine Market: Pharmaceutical and Biotechnology Companies (2017-2022) & (M Doses)
Figure 21. Haemophilus Influenzae Type B Vaccine Consumed in Academic Institutions
Figure 22. Global Haemophilus Influenzae Type B Vaccine Market: Academic Institutions (2017-2022) & (M Doses)
Figure 23. Haemophilus Influenzae Type B Vaccine Consumed in Other
Figure 24. Global Haemophilus Influenzae Type B Vaccine Market: Other (2017-2022) & (M Doses)
Figure 25. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2017-2022)
Figure 26. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application in 2021
Figure 27. Haemophilus Influenzae Type B Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 28. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Company in 2021
Figure 29. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 30. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Geographic Region in 2021
Figure 31. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Region (2017-2022)
Figure 32. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country/Region in 2021
Figure 33. Americas Haemophilus Influenzae Type B Vaccine Sales 2017-2022 (M Doses)
Figure 34. Americas Haemophilus Influenzae Type B Vaccine Revenue 2017-2022 ($ Millions)
Figure 35. APAC Haemophilus Influenzae Type B Vaccine Sales 2017-2022 (M Doses)
Figure 36. APAC Haemophilus Influenzae Type B Vaccine Revenue 2017-2022 ($ Millions)
Figure 37. Europe Haemophilus Influenzae Type B Vaccine Sales 2017-2022 (M Doses)
Figure 38. Europe Haemophilus Influenzae Type B Vaccine Revenue 2017-2022 ($ Millions)
Figure 39. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales 2017-2022 (M Doses)
Figure 40. Middle East & Africa Haemophilus Influenzae Type B Vaccine Revenue 2017-2022 ($ Millions)
Figure 41. Americas Haemophilus Influenzae Type B Vaccine Sales Market Share by Country in 2021
Figure 42. Americas Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country in 2021
Figure 43. United States Haemophilus Influenzae Type B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Canada Haemophilus Influenzae Type B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. Mexico Haemophilus Influenzae Type B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Brazil Haemophilus Influenzae Type B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 47. APAC Haemophilus Influenzae Type B Vaccine Sales Market Share by Region in 2021
Figure 48. APAC Haemophilus Influenzae Type B Vaccine Revenue Market Share by Regions in 2021
Figure 49. China Haemophilus Influenzae Type B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 50. Japan Haemophilus Influenzae Type B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 51. South Korea Haemophilus Influenzae Type B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. Southeast Asia Haemophilus Influenzae Type B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. India Haemophilus Influenzae Type B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Australia Haemophilus Influenzae Type B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 55. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Country in 2021
Figure 56. Europe Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country in 2021
Figure 57. Germany Haemophilus Influenzae Type B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 58. France Haemophilus Influenzae Type B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. UK Haemophilus Influenzae Type B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. Italy Haemophilus Influenzae Type B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Russia Haemophilus Influenzae Type B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 62. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales Market Share by Country in 2021
Figure 63. Middle East & Africa Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country in 2021
Figure 64. Egypt Haemophilus Influenzae Type B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 65. South Africa Haemophilus Influenzae Type B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 66. Israel Haemophilus Influenzae Type B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 67. Turkey Haemophilus Influenzae Type B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 68. GCC Country Haemophilus Influenzae Type B Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 69. Manufacturing Cost Structure Analysis of Haemophilus Influenzae Type B Vaccine in 2021
Figure 70. Manufacturing Process Analysis of Haemophilus Influenzae Type B Vaccine
Figure 71. Industry Chain Structure of Haemophilus Influenzae Type B Vaccine
Figure 72. Channels of Distribution
Figure 73. Distributors Profiles
